TumCD Cancer Research Results
TumCD, Tumor Cell Death: Click to Expand ⟱
| Source: |
| Type: |
Tumor Cell Death
|
Scientific Papers found: Click to Expand⟱
compI↓, Previous research has shown that metformin, which is an inhibitor of complex I of the respiratory chain, may inhibit some brain tumor initiating cells (BTICs), albeit at dosages that are too high for clinical use.
Glycolysis↓, explored whether a combined treatment of metformin and diclofenac, which is a non-steroidal anti-inflammatory drug (NSAID) shown to inhibit glycolysis
OCR↓, However, we observed that metformin inhibited cellular oxygen consumption and increased extracellular lactate levels, indicating glycolytic rescue mechanisms
Glycolysis↑,
lactateProd↓, Combined treatment inhibited metformin-induced lactate increase.
eff↑, Combined treatment may reduce the effective doses of the single agents and prevent metabolic rescue mechanisms.
TumCP↓, Combined Treatment of Metformin and Diclofenac Impairs Cell Proliferation and Migration
TumCMig↓,
TumCD∅, Metformin, Diclofenac, and Combined Treatment at Low Doses Do Not Increase Cell Death
Ca+2↑, After exposure to electromagnetic fields the basal [Ca(2+)](i) levels increased significantly from 143 +/- 46 nM to 278 +/- 125 nM
TumCP∅, Moreover the electromagnetic fields that affected [Ca(2+)](i) did not cause cell proliferation or cell death and the proliferation indexes remained unchanged after exposure.
TumCD∅,
eff↑, However, the [Ca 2+]i levels in normal and caffeine-treated cells were signicantly higher after EMF exposure than in sham exposed cells
exposed cells
TumCD∅, We found that PSO and RA-RF were not toxic to TNF-α-induced A549 cells.
ROS↓, Both extracts significantly decreased the generation of reactive oxygen species (ROS) in this cell line.
IL1β↓, mRNA expression levels of IL-1β, IL-6, IL-8, TNF-α, and COX-2 were significantly decreased by the treatment of PSO and RA-RF.
IL6↓,
IL8↓,
TNF-α↓,
COX2↓,
SOD2↓, MnSOD, FOXO1, and NF-κB and phosphorylation of JNK were also significantly diminished by PSO and RA-RF treatment
FOXO1↓,
NF-kB↓,
JNK↓,
antiOx↑, PSO and RA-RF act as antioxidants
tumCV∅, PSO and RA-RF had no effect on A549 cell viability.
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, compI↓, 1, ROS↓, 1, SOD2↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
OCR↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
Glycolysis↓, 1, Glycolysis↑, 1, lactateProd↓, 1,
Cell Death(tgid=5) ⓘ
JNK↓, 1, TumCD∅, 3,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV∅, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
FOXO1↓, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 1, TumCMig↓, 1, TumCP↓, 1, TumCP∅, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2↓, 1, IL1β↓, 1, IL6↓, 1, IL8↓, 1, NF-kB↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↑, 2,
Clinical Biomarkers(tgid=22) ⓘ
IL6↓, 1,
Total Targets: 24
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: TumCD, Tumor Cell Death
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:619 State#:% Dir#:6
wNotes=on sortOrder:rid,rpid
Home Page